BioIntel Venture Fund, L.P. — Form D/A
BioIntel Venture Fund, L.P. of SEATTLE, WA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-08-12. $110.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-08-12
- Form: D/A
- Accession: 0001012975-25-000429
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $110.9M
- Minimum investment: $100K
- Investors: 28
- Date of first sale: 2024-08-16
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-521239
Issuer
- Name: BioIntel Venture Fund, L.P.
- CIK: 0002031377
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 814 EAST HIGHLAND DRIVE, SEATTLE, WA, 98102
- Phone: 425-503-9166
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A BioIntel Venture Partners GP, LLC | Director | Seattle, WA |
| N/A BioIntel Venture Partners, L.P. | Director | Seattle, WA |
| Boris Nikolic | Executive Officer | Atlanta, GA |
Other filings by this issuer (1)
More